PremiumClass ActionBiohaven Faces Investor Fury Over Misleading Claims FDA flags possible safety signals in new report, says RBC Capital 3 Best Stocks to Buy Now, 6/19/2025, According to Top Analysts PremiumMarket News3 Best Stocks to Buy Now, 5/30/2025, According to Top Analysts Biohaven Ltd. Receives Buy Rating from Douglas Tsao Amid Promising R&D Advancements and Strategic Developments Biohaven Ltd. Receives Buy Rating Amidst Promising Developments and Strategic Advancements PremiumThe FlyBiohaven provides oncology program update RBC downgrades Biohaven to Sector Perform on regulatory risk Biohaven downgraded to Sector Perform from Outperform at RBC Capital 
